{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:53:55Z","timestamp":1772121235006,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.metabol.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T04:00:36Z","timestamp":1367812836000},"page":"1313-1322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program"],"prefix":"10.1016","volume":"62","author":[{"given":"Sherita Hill","family":"Golden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Barrett-Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengchun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2013.04.005_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2013.04.005_bb0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2013.04.005_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2013.04.005_bb0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2013.04.005_bb0025","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2013.04.005_bb0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.288.19.2432","article-title":"Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial","volume":"288","author":"Waters","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2013.04.005_bb0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2013.04.005_bb0040","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.88.5.2163","article-title":"Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group","volume":"88","author":"Manolio","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2013.04.005_bb0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM199304153281501","article-title":"Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators","volume":"328","author":"Nabulsi","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2013.04.005_bb0050","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/archinte.1993.00410190036005","article-title":"The impact of female hormone usage on the lipid profile. The Framingham Offspring Study","volume":"153","author":"Vaziri","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2013.04.005_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2013.04.005_bb0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-8529(18)30240-8","article-title":"Plasma steroid-binding proteins","volume":"20","author":"Rosner","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.metabol.2013.04.005_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1365-2362.1996.145278.x","article-title":"Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue","volume":"26","author":"Pedersen","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2013.04.005_bb0070","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1365-2362.1996.380603.x","article-title":"Identification of steroid receptors in human adipose tissue","volume":"26","author":"Pedersen","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2013.04.005_bb0075","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1172\/JCI113667","article-title":"Relationship between lipoprotein lipase activity and plasma sex steroid levels in obese women","volume":"82","author":"Iverius","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2013.04.005_bb0080","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974\u20132000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2013.04.005_bb0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0764-4469(00)88529-7","article-title":"Catabolism of HDL1 cholesteryl ester in the rat. Effect of ethinyl estradiol treatment","volume":"322","author":"Serougne","year":"1999","journal-title":"C R Acad Sci III"},{"key":"10.1016\/j.metabol.2013.04.005_bb0090","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.2009.24.9557","article-title":"Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women","volume":"28","author":"Friedenreich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2013.04.005_bb0095","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/1055-9965.1099.13.7","article-title":"Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial","volume":"13","author":"McTiernan","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2013.04.005_bb0100","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/0008-5472.CAN-03-3393","article-title":"Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial","volume":"64","author":"McTiernan","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2013.04.005_bb0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2013.04.005_bb0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/gme.0b013e3182703b73","article-title":"Reduction in Glucose Among Postmenopausal Women Who Use and Do Not Use Estrogen Therapy","volume":"20","author":"Kim","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.metabol.2013.04.005_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2013.04.005_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","article-title":"Enzymatic methods for quantification of lipoprotein lipids","volume":"129","author":"Warnick","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.metabol.2013.04.005_bb0125","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2013.04.005_bb0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2013.04.005_bb0135","series-title":"Lipid Research Clinics Program, Lipid and Lipoprotein Analysis, Manual of Laboratory Operations","author":"U.S Department of Health and Human Services","year":"1983"},{"key":"10.1016\/j.metabol.2013.04.005_bb0140","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2012-1233","article-title":"Endogenous Sex hormone changes in postmenopausal women in the diabetes prevention program","volume":"97","author":"Kim","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.04.005_bb0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0022-4731(82)90038-3","article-title":"Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature","volume":"16","author":"Sodergard","year":"1982","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.metabol.2013.04.005_bb0150","first-page":"649","article-title":"Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period","volume":"4","author":"Hankinson","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2013.04.005_bb0155","first-page":"509","article-title":"Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma","volume":"4","author":"Bolelli","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2013.04.005_bb0160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2006.02624.x","article-title":"Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study","volume":"65","author":"Laughlin","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2013.04.005_bb0165","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/db07-0009","article-title":"Body size and shape changes and the risk of diabetes in the diabetes prevention program","volume":"56","author":"Fujimoto","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2013.04.005_bb0170","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.54.8.2404","article-title":"Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin","volume":"54","author":"Kitabchi","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2013.04.005_bb0175","doi-asserted-by":"crossref","first-page":"E411","DOI":"10.1152\/ajpendo.00317.2003","article-title":"5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle","volume":"286","author":"Frosig","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.04.005_bb0180","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.metabol.2006.04.007","article-title":"Long-term exercise stimulates adenosine monophosphate-activated protein kinase activity and subunit expression in rat visceral adipose tissue and liver","volume":"55","author":"Takekoshi","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.04.005_bb0185","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.metabol.2009.04.024","article-title":"Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase","volume":"58","author":"Ohira","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.04.005_bb0190","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00125-011-2126-4","article-title":"AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study","volume":"54","author":"Boyle","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2013.04.005_bb0195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1210\/jcem-57-2-262","article-title":"The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females","volume":"57","author":"Schaefer","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.04.005_bb0200","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3mg drospirenone plus 20 mug ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2013.04.005_bb0205","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2013.04.005_bb0210","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2013.04.005_bb0215","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.47.10.1643","article-title":"Prevalence of insulin resistance in metabolic disorders: the Bruneck Study","volume":"47","author":"Bonora","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2013.04.005_bb0220","first-page":"3955","article-title":"Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women","volume":"82","author":"Campos","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.04.005_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.exger.2009.10.014","article-title":"Hypercholesterolemia and 3-hydroxy-3-methylglutaryl coenzyme A reductase regulation in aged female rats","volume":"45","author":"Trapani","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.metabol.2013.04.005_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:02:14Z","timestamp":1758427334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0026049513001029"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.04.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718021978.793479074","asserted-by":"object"}]},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}